Kim Rivers Sells 400,000 Shares of Trulieve Cannabis (NYSE:TRLV) Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 400,000 shares of the stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $8.17, for a total value of $3,268,000.00. Following the sale, the chief executive officer owned 1,913,724 shares of the company’s stock, valued at approximately $15,635,125.08. The trade was a 17.29% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Stock Up 4.8%

TRLV opened at $8.93 on Friday. Trulieve Cannabis Corp. has a 12-month low of $3.50 and a 12-month high of $13.28.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on TRLV shares. Weiss Ratings assumed coverage on shares of Trulieve Cannabis in a research report on Tuesday, June 16th. They set a “sell (d-)” rating on the stock. Zacks Research raised shares of Trulieve Cannabis to a “hold” rating in a report on Thursday, June 18th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Trulieve Cannabis has an average rating of “Reduce”.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.